Format

Send to

Choose Destination
Cathet Cardiovasc Diagn. 1998 Nov;45(3):264-8.

Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease.

Author information

1
Department of Pediatrics, University of Utah and Primary Children's Medical Center, Salt Lake City 84113, USA. pcs ether@ihc.com

Abstract

A 4-month-old girl with Kawasaki disease, large coronary artery aneurysms, and coronary thrombi was treated with standard therapy followed by abciximab, a platelet glycoprotein IIb/IIIa antagonist, in addition to standard heparin and warfarin sodium anticoagulation and low-dose aspirin. She did not develop evidence of ischemia, had no complications from the therapy, and showed resolution of the aneurysms and thrombi after 6 wk of therapy.

PMID:
9829884
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center